Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
Clinical trial NCT00529113 · TERMINATED
Trial details
- NCT number
- NCT00529113
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-30
- Primary completion
- 2009-11-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.